Standard Life plc
11 August 2026
LEI: 2138001P49OLAEU33T68
STANDARD LIFE PLC (the 'Company')
ADMISSION TO TRADING
This announcement is made in accordance with the Financial Conduct Authority's Prospectus Rules: Admission to Trading on a Regulated Market (PRM) sourcebook 1.6.4R.
The following shares have been admitted to trading on the Main Market at the London Stock Exchange under the company's existing block admissions of shares pursuant to their allotment under the Company's ShareSave plan.
|
1 |
Details of the issuer |
|
|
a) |
Name: |
Standard Life plc |
|
b)
|
LEI: |
2138001P49OLAEU33T68 |
|
2 |
Details of the transferable securities admitted to trading |
|
|
a) |
Regulated market: |
London Stock Exchange (XLON) |
|
b) |
Name, type and ISIN of the shares: |
Standard Life plc Ordinary Shares of 10 pence GB00BGXQNP29 |
|
c) |
Number of further securities issues and admitted: |
121,338 |
|
d) |
Total number of securities in issue following admission: |
1,006,836,640 |
|
e) |
Confirmation that the new shares are fungible with existing ordinary shares already admitted to trading: |
Confirmed |
|
3 |
Admission details
|
|
|
a) |
Date of admission: |
12 June 2026 to 11 August 2026 |
|
b) |
Prospectus information: |
Not applicable |
Enquiries:
|
Media +44 (0) 204 559 3031 |
InvestorsClaire Hawkins, Director of Corporate Affairs & Chief of Staff, Standard Life plc +44 (0) 204 559 3161  |
|
Tom Blackwell Managing Director, FTI +44 (0) 7747 113 919 |
Joanne Roberts, Investor Relations Director, Standard Life plc +44 (0) 204 559 4673 |
NOTE: Please email any major shareholding notifications under DTR 5.1.2 R to the Group Company Secretary (kulbinder.dosanjh@standardlife.com) copying in joanne.roberts@standardlife.com and vickie.reuben@standardlife.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.